Lee Ching Yin, Tamura Taku, Rabah Nadia, Lee Dong-Young Donna, Ruel Isabelle, Hafiane Anouar, Iatan Iulia, Nyholt Dana, Laporte Frédéric, Lazure Claude, Wada Ikuo, Krimbou Larbi, Genest Jacques
Cardiovascular Genetics Laboratory, Cardiology Division, McGill University Health Center/Royal Victoria Hospital, Montréal, Québec H3A 1A1, Canada.
Biochemistry. 2007 Dec 25;46(51):14969-78. doi: 10.1021/bi700817g. Epub 2007 Dec 1.
The human acid sphingomyelinase (ASM, EC 3.1.4.12), a lysosomal and secretory protein coded by the sphingomyelin phosphodiesterase 1 (SMPD-1) gene, catalyzes the degradation of sphingomyelin (SM) to ceramide and phosphorylcholine. We examined the structural-functional properties of its carboxyl-terminus (amino acids 462-629), which harbors approximately 1/3 of all mutations discovered in the SMPD-1 gene. We created four naturally occurring mutants (DeltaR608, R496L, G577A, and Y537H) and five serial carboxyl-terminal deletion mutants (N620, N590, N570, N510, and N490). Transient transfection of the His/V5-tagged wild-type and mutant recombinant ASM in Chinese hamster ovary cells showed that all the mutants were normally expressed. Nonetheless, none of them, except the smallest deletion mutant N620 that preserved all post-translational modifications, were found capable of secretion to the medium. Furthermore, only the N620 conserved functional integrity (100% activity of the wild type); all other mutants completely lost the ability to catalyze SM hydrolysis. Importantly, cell surface biotinylation revealed that mutant DeltaR608 transfected CHO cells and fibroblasts from a compound heterozygous Niemann-Pick disease type B (NPD-B) patient (DeltaR608 and R441X) have defective translocation to the plasma membrane. Furthermore, we demonstrated that the DeltaR608 and N590 were trapped in the endoplasmic reticulum (ER) quality control checkpoint in contrast to the wild-type lysosomal localization. Interestingly, while the steady-state levels of ubiquitination were minimal for the wild-type ASM, a significant amount of Lys63-linked polyubiquitinated DeltaR608 and N590 could be purified by S5a-affinity chromatography, indicating an important misfolding in the carboxyl-terminal mutants. Altogether, we provide evidence that the carboxyl-terminus of the ASM is crucial for its protein structure, which in turns dictates the enzymatic function and secretion.
人酸性鞘磷脂酶(ASM,EC 3.1.4.12)是一种由鞘磷脂磷酸二酯酶1(SMPD-1)基因编码的溶酶体和分泌蛋白,催化鞘磷脂(SM)降解为神经酰胺和磷酸胆碱。我们研究了其羧基末端(氨基酸462 - 629)的结构功能特性,该区域包含了在SMPD-1基因中发现的所有突变的约1/3。我们构建了四个天然存在的突变体(DeltaR608、R496L、G577A和Y537H)以及五个连续的羧基末端缺失突变体(N620、N590、N570、N510和N490)。在中国仓鼠卵巢细胞中对His/V5标签的野生型和突变体重组ASM进行瞬时转染,结果显示所有突变体均正常表达。然而,除了保留所有翻译后修饰的最小缺失突变体N620外,其他突变体均不能分泌到培养基中。此外,只有N620保留了功能完整性(野生型活性的100%);所有其他突变体完全丧失了催化SM水解的能力。重要的是,细胞表面生物素化显示,转染了突变体DeltaR608的CHO细胞以及来自B型尼曼-匹克病(NPD-B)复合杂合患者(DeltaR608和R441X)的成纤维细胞向质膜的转运存在缺陷。此外,我们证明与野生型溶酶体定位不同,DeltaR608和N590被困在内质网(ER)质量控制检查点。有趣的是,虽然野生型ASM的泛素化稳态水平极低,但通过S5a亲和层析可以纯化出大量与赖氨酸63连接的多泛素化DeltaR608和N590,这表明羧基末端突变体存在重要的错误折叠。总之,我们提供的证据表明,ASM的羧基末端对其蛋白质结构至关重要,而蛋白质结构又决定了酶的功能和分泌。